Trials / Unknown
UnknownNCT03141619
Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Dr. Gordon Boyd · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to test the hypothesis that poor cerebral perfusion during critical illness is a risk factor for acute and long-term neurological dysfunction among survivors. We use near-infrared spectroscopy to measure brain tissue oxygenation as a non-invasive surrogate marker for cerebral perfusion. Acute neurological dysfunction is defined as the presence of delirium, which is assessed using the Confusion Assessment Method-Intensive Care Unit (CAM-ICU). Chronic neurological dysfunction is defined as having quantitative impairments on robotic testing (KINARM robot) and traditional neuropsychological screening (Repeatable Battery for the Assessment of Neuropsychological Status).
Conditions
Timeline
- Start date
- 2017-10-13
- Primary completion
- 2024-06-01
- Completion
- 2025-06-01
- First posted
- 2017-05-05
- Last updated
- 2023-12-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03141619. Inclusion in this directory is not an endorsement.